EODData

MEMBERSHIP REGISTER LOG IN

FRA, RGN: Repligen Corporation

07 Nov 2025
LAST:

124.4

CHANGE:
 0.75		OPEN:
124.4		HIGH:
124.4		ASK:
0.0		VOLUME:
105
CHG(%):
0.60		PREV:
125.1		LOW:
124.4		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 25124.4124.4124.4124.4105
06 Nov 25125.1125.1125.1125.1105
05 Nov 25126.6126.6126.6126.6105
04 Nov 25128.0128.0128.0128.0105
03 Nov 25127.7127.7127.7127.7105
31 Oct 25123.4123.4123.4123.4105
30 Oct 25126.3126.8126.3126.8105
29 Oct 25129.2129.2129.2129.2105
28 Oct 25136.4136.4136.4136.4105
27 Oct 25142.5142.5138.2138.2105

COMPANY PROFILE

Name:Repligen Corporation
About:Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Medical Instruments & Supplies
Address:Building 1, Waltham, MA, United States, 02453
Website:https://www.repligen.com
ISIN:US7599161095
LEI:54930006QJ0T5AUO1E71

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:12,765.00 
Forward P/E:42.27 
PEG Ratio:79.78 
Price to Sales:10.59 
Price to Book:3.48 
Profit Margin:0.00 
Operating Margin:0.09 
Return on Assets:-0.01 
Return on Equity:-0.01 
Revenue:614.38M 
EBITDA:41.33M 
Shares:56.26M 
Market Cap:6.996B 

TECHNICAL INDICATORS

MA5:126.331.6%
MA10:128.553.4%
MA20:129.444.1%
MA50:116.117.1%
MA100:109.7213.3%
MA200:117.985.4%
STO9:7.69 
STO14:5.24 
RSI14:42.86
WPR14:-94.37 
MTM14:-6.95
ROC14:-0.05 
ATR:2.81 
Week High:128.002.9%
Week Low:123.350.8%
Month High:142.4514.6%
Month Low:123.355.4%
Year High:168.8935.8%
Year Low:93.8232.5%